Lexaria Bioscience Corp. has taken reasonable care in producing and publishing information contained on this web site and will endeavour to update it regularly. Material on this site may contain technical or other inaccuracies, or not be up to date at any given moment in time and must not be relied upon for any material purposes.
No statement in this web site has been evaluated by the Food and Drug Administration (FDA). Furthermore, none of the statements in this web site should be construed as dispensing medical advice or making claims regarding the cure of diseases. Lexaria, Lexaria Bioscience Corp., and DehydraTECH-enabled products are not intended to diagnose, treat, cure or prevent any disease.
No information within this website should be relied upon to make investment decisions, all investment decisions should be made with the assistance of a licensed financial professional. This website makes no solicitation for financing.
This website includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements.
Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the pharmaceutical, medical marijuana, CBD, or alternative health sectors will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that any planned corporate activity, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that any DehydraTECH-enabled product will promote, assist, or maintain any beneficial human health conditions whatsoever.